The global bacterial & viral specimen collection market size is projected to reach USD 38.8 billion by 2027, registering a CAGR of 14.0%, as per a new report by Grand View Research Inc. The advent of high-end methods, including multiplex PCR, next-generation sequencing, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry have allowed robust diseases diagnosis and rapid microbial identification.
A rise in the prevalence of infectious ailments has impelled industry players offer affordable and easy-to-use tests. As per the 2020 report by the Centers for Disease Control and Prevention (CDC), there were approximately 8,920 new Tuberculosis (TB) cases in the U.S. Such instances have driven the development of medical technology. In July 2020, the Foundation for Innovative New Diagnostics and Cepheid, Inc. launched Xpert MTB/XDR, a rapid molecular test for drug-resistance TB profiling. Similar trends are spurring the market growth.
Operating end-users including clinical laboratories are following standardized protocols to streamline the usage of market products. This is because inaccurate results during specimen collection can affect patient care, laboratory efficiency, hospital infection control, and associated costs. The Texas Department of State Health Services is such regulatory agency that is engaged in rolling out guidelines for suitable collecting and processing methods, thus positively influencing the market growth.
Bacterial & Viral Specimen Collection Market Highlights
According to the American Chemical Society, ultra-absorptive nanofiber swabs can provide rapid and sensitive diagnosis of SARS-CoV-2 virus. The porous nanofiber cylinders promises to minimize the number of false-negative tests. Presently, the most optimal test for COVID-19 strain involves using a long swab for specimen collection from deep inside a patient’s nose. Later the specimen is tested using reverse transcriptase-polymerase chain reaction (RT-PCR) method to detect SARS-CoV-2 RNA
In January 2021, GenTegra announced the validation of their two novel sample collection tube devices called as the direct-into-PCR GenTegra GTR-STMdk™ and GenTegra GTR-STM™. The Active Chemical Protection™ (ACP) technology has been incorporated in these devices to eliminates the need for time consuming and expensive RNA extraction in Covid-19 detection tests
In January 2021, Helix Specialty Diagnostics entered in a collaboration with Genomic LTC DX to develop the Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Covid-19 testing kits on the Biomark HD platform. This development aims to facilitate 3,000 tests per day
In January 2021, EKF Diagnostics has increased the production of their new PrimeStore MTM, in addition to their previous portfolio: the Kantaro COVID-SeroKlir SARS-CoV-2 IgG antibody test kit under the COVID-19 testing regime
Asia Pacific market is projected to register a lucrative growth rate in the coming years due to several initiatives undertaken by the emerging economies. For instance, China emerged as the primary exporter of Coivid-19 testing kits to Europe and other parts of the world
“Would you Like/Try a Sample Report” Click the link below:https://www.grandviewresearch.com/industry-analysis/bacterial-viral-specimen-collection-market/request/rs1
Bacterial & Viral Specimen Collection Market Segmentations
Grand View Research has segmented the global bacterial and viral specimen collection market on the basis of product, application, end-use, and region:
Bacterial & Viral Specimen Collection Product Outlook (Revenue, USD Million, 2016 – 2027)
Bacterial Specimen Collection
Swabs
Bacterial Transport Media
Blood Collection Kits
Other Consumables
Viral Specimen Collection
Viral Transport Media
Bacterial & Viral Specimen Collection Application Outlook (Revenue, USD Million, 2016 – 2027)
Diagnostics
Research
Bacterial & Viral Specimen Collection End-use Outlook (Revenue, USD Million, 2016 – 2027)
Hospitals & Clinics
Home Test
Research Laboratories
Bacterial & Viral Specimen Collection Regional Outlook (Revenue, USD Million, 2016 – 2027)
North America
The U.S.
Canada
Europe
Germany
The U.K.
France
Italy
Spain
Asia Pacific
China
Japan
India
South Korea
Latin America
Brazil
Mexico
Middle East & Africa (MEA)
South Africa
UAE
List of Key Players of Bacterial & Viral Specimen Collection Market
Puritan Medical Products
COPAN Diagnostics
Becton, Dickinson and Company
Thermo Fisher Scientific, Inc.
Quidel Corporation
Longhorn Vaccines and Diagnostics, LLC
Pretium Packaging
Trinity Biotech
Medical Wire & Equipment
HiMedia Laboratories
Hardy Diagnostics
Nest Scientific
VIRCELL S.L.
DiaSorin
Titan Biotech
Have Any Query? Ask Our Experts for More Details on Report:https://www.grandviewresearch.com/inquiry/450898/ibb
Browse Related Report @
Blood Culture Tests Market – https://www.grandviewresearch.com/industry-analysis/blood-culture-tests-market
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research is a market research and consulting company that offers market research reports, syndicated and customized reports. The company is headquartered in San Francisco, California. It offers client engagement for business consulting and market intelligence from various domains. The clientele is based across various countries with queries coming from more than 50 industries worldwide. Grand View Research helps its clients to make informed decisions by helping them understand current trends and scenarios. Every year Grand View Research accomplishes more than 300 multi-country market studies to optimize consulting for clients.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1888202951Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United StatesCity: San FranciscoState: CaliforniaCountry: United StatesWebsite: https://www.grandviewresearch.com/industry-analysis/bacterial-viral-specimen-collection-market